Cargando…
Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
BACKGROUND AND PURPOSE: Comorbidity in myasthenia gravis (MG) is important for diagnosis, treatment and prognosis. Disease complexity was assessed by examining total drug treatment, immune therapy and comorbidity in a complete national MG cohort. METHODS: All recipients of the MG-specific drug pyrid...
Autores principales: | Andersen, J B, Owe, J F, Engeland, A, Gilhus, N E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238850/ https://www.ncbi.nlm.nih.gov/pubmed/24712740 http://dx.doi.org/10.1111/ene.12439 |
Ejemplares similares
-
Complicating autoimmune diseases in myasthenia gravis: a review
por: Nacu, Aliona, et al.
Publicado: (2015) -
Myasthenia Gravis: A Review of Available Treatment Approaches
por: Gilhus, Nils Erik, et al.
Publicado: (2011) -
Advances and challenges in the treatment of myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2021) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Immunoactive treatment for myasthenia gravis; a Chinese experience
por: Gilhus, Nils Erik
Publicado: (2020)